The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study*Yan Zhao, J Zhang, Qianjin Lu et al.|British Journal of Dermatology|2021Cited by 73